“Blood factor II”的搜索结果，显示 151-160 项，共有 4180 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... 2 participants will also undergo MRI scanning, comprehensive cognitive assessment batteries and longitudinal blood collection; and Tier 3 participants will ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. ... II, maintenance), with some patients ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... factor receptor 2 negative (ER+/HER2-) advanced or metastatic breast cancer that has progressed on treatment with everolimus in combination with exemestane ...

4. 头颈癌中心- 临床试验- 妙佑医疗国际

   ... II). Additinoally, to evaluate the effectiveness ... A Study to Identify Biomarkers in the Blood, Saliva or Tissue for Oropharyngeal Squamous Cell Cancer ... II).

5. 外科 - 临床试验- 妙佑医疗国际

   ... blood pressure, despite use of two anti-hypertensive medications and lifestyle changes. The novelty of the RPDTM system relates to its placement via natural ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Blood Collection Protocol to Study the Immune Responses of Cancer Patients with Malignancies ... This is a peripheral blood ... This randomized phase II trial ...

7. 神经科- 临床试验- 妙佑医疗国际

   To identify demographic, clinical and radiologic factors ... 2 or 3 meningioma as measured by 6-month PFS rate. ... blood collection; and Tier 3 participants will ...

8. 血液科- 临床试验- 妙佑医疗国际

   ... II dose (RP2D of APG2575 in combination with ... blood-based (hematologic) cancers. Increasing CLL ... blood and bone marrow cancers. NGS is a ...

9. 心血管医学- 临床试验- 妙佑医疗国际

   The purpose of this study is to better understand the relationship between exercise, breathing, blood flow and blood pressure. This study includes two study ...

10. 血液科- 临床试验- 妙佑医疗国际

    ... II dose (RP2D of APG2575 in combination with ... A Blood Collection Protocol to Study the Immune Responses of Cancer Patients with Malignancies ... In addition to ...